He Yuan, Jia Senhao, Sun Guoyi, Cao Long, Wang Xinhao, Zhang Hongpeng, Jia Xin, Ma Xiaohui, Xiong Jiang, Liu Xiaoping, Guo Wei
Department of Vascular Surgery, Chinese PLA General Hospital, Haidian District, Beijing, People's Republic of China.
Department of General Surgery, Chinese PLA No. 983 Hospital, Hebei District, Tianjin, People's Republic of China.
Vasc Endovascular Surg. 2020 Aug;54(6):510-518. doi: 10.1177/1538574420927131. Epub 2020 May 21.
Patients who have survived an acute aortic dissection remain at risk for postdissection thoracoabdominal aortic aneurysms (PD-TAAAs). Fenestrated/branched endovascular repair for PD-TAAA is increasingly used in some high-volume centers, but outcomes are still limited because of the additional challenges compared to atherosclerotic thoracoabdominal aneurysms. This study was performed to evaluate the literature on fenestrated/branched endovascular repair for PD-TAAAs.
PubMed, Embase, and the Cochrane Database were searched for relevant studies published until September 2019. Outcome data were extracted to evaluate the technical success, 30-day mortality, later survival, major complications, endoleaks, target vessel patency, and reintervention. Studies were analyzed in a pooled proportion meta-analysis.
In total, 143 patients from 4 studies were identified for the pooled data analysis. The pooled technical success rate was 98% (95% CI: 86%-100%). After the treatment, the overall estimated 30-day mortality rate was 3% (95% CI: 1%-8%), early spinal cord ischemia rate was 10% (95% CI: 4%-21%), early renal injury rate was 5% (95% CI: 1%-19%), endoleak rate was 33% (95% CI: 22%-47%), reintervention rate at a median follow-up of 22.5 months was 34% (95% CI: 27%-42%), and all-cause mortality rate was 12% (95% CI: 6%-24%).
The use of fenestrated/branched stent grafts for the treatment of PD-TAAA appears generally feasible based on the limited literature, but endoleaks and reinterventions are frequent.
急性主动脉夹层幸存者仍有发生夹层后胸腹主动脉瘤(PD-TAAA)的风险。在一些高容量中心,开窗/分支型血管腔内修复术治疗PD-TAAA的应用越来越多,但与动脉粥样硬化性胸腹主动脉瘤相比,由于存在额外挑战,其疗效仍有限。本研究旨在评估开窗/分支型血管腔内修复术治疗PD-TAAA的文献。
检索PubMed、Embase和Cochrane数据库,查找截至2019年9月发表的相关研究。提取结局数据以评估技术成功率、30天死亡率、后期生存率、主要并发症、内漏、靶血管通畅率和再次干预情况。采用合并比例荟萃分析对研究进行分析。
总共从4项研究中纳入143例患者进行汇总数据分析。汇总技术成功率为98%(95%CI:86%-100%)。治疗后,总体估计30天死亡率为3%(95%CI:1%-8%),早期脊髓缺血率为10%(95%CI:4%-21%),早期肾损伤率为5%(95%CI:1%-19%),内漏率为33%(95%CI:22%-47%),中位随访22.5个月时的再次干预率为34%(95%CI:27%-42%),全因死亡率为12%(95%CI:6%-24%)。
基于有限的文献,使用开窗/分支型覆膜支架治疗PD-TAAA总体上似乎可行,但内漏和再次干预很常见。